戴明环循环管理在提高门诊处方合理率中的应用价值

doi:10.19803/j.1672-8629.2022.09.22

中国药物警戒 ›› 2022, Vol. 19 ›› Issue (9): 1035-1039.
DOI: 10.19803/j.1672-8629.2022.09.22

戴明环循环管理在提高门诊处方合理率中的应用价值

刘斌, 邵美玲, 蔡怡然, 马丰懿, 兰鸿^*

十堰市太和医院药学部,湖北医药学院附属医院,湖北十堰 442000

收稿日期:2021-02-04 出版日期:2022-09-15 发布日期:2022-09-16
通讯作者: ^*兰鸿,男,硕士,副主任药师,药事管理。E-mail: lh76117611@163.com
作者简介:刘斌,男,硕士,药师,临床药学。
基金资助:
湖北省技术创新专项重大项目（2017ACA176）

Applicability of PDCA cycle in standardization of outpatient prescriptions

LIU Bin, SHAO Meiling, CAI Yiran, MA Fengyi, LAN Hong^*

Department of Pharmacy, Taihe Hospital Affiliated to Hubei University of Medicine, Shiyan Hubei 442000, China

Received:2021-02-04 Online:2022-09-15 Published:2022-09-16

摘要/Abstract

摘要： 目的通过对某院康复药房门诊处方合理率统计及不合理分析,探讨戴明环（plan-do-check-action, PDCA）在提高门诊处方合理率中的应用价值,以减少用药错误,降低药品费用,进而减轻患者医疗负担,提高医疗服务质量。方法采用随机数字法抽取某院康复药房2019年11月1日至2020年6月30日期间（干预前）2 000张门诊处方进行统计分析,计算该段时间内门诊处方合理率及不合理类型分布和占比,根据分析结果采用PDCA循环模式管理采取有效措施干预,并对2020年7月1日至2020年10月31日期间（干预后）1 000张门诊不合理处方进行统计分析。结果在2019年11月1日至2020年6月30日期间平均处方合理率为88.8%,不符合国家大于95%的要求;通过PDCA管理模式干预之后,在2020年7月1日至2020年10月31日期间处方合理率为95.70%,符合国家大于95%的要求,处方合理率呈现出逐月增高的趋势,从干预前最低的86.27%,到干预后最高的96.38%。按照有形成果的目标达成率计算结果为111.29%,进步率为7.77%。结论 PDCA在门诊处方质量管理中具有显著效果,可以有效提高门诊处方合理率,使医院药事服务质量得到大幅提升,为患者的用药安全提供强有力的保障。

关键词: 康复药房, 处方分析, 戴明环（PDCA）, 合理用药

Abstract: Objective To explore the applicability of the PDCA cycle in standardizing outpatient prescriptions in our hospital so as to reduce medication errors and drug costs. Methods A total of 2 000 outpatient prescriptions were selected using the random number table method between November 1, 2019 and June 30, 2020 (before intervention). The rate of qualification of outpatient prescriptions and the distribution and proportion of substandard ones were calculated. Based on the results of analysis, the PDCA cycle was adopted for intervention. 1 000 problematic outpatient prescriptions were statistically analyzed between July 1, 2020 and October 31, 2020 (after intervention). Results From November 1, 2019 to June 30, 2020, the rate of qualification of prescriptions averaged 88.8%, which failed to meet the national requirement (over 95%). After the intervention by the PDCA cycle, the rate of qualification of prescriptions not only rose to 95.70% between July 1, 2020 and October 31, 2020, which met the national requirement, but maintained a trend of month-on-month increase, from the lowest (86.27%) before intervention to the highest (96.38%) after the intervention. The achievement rate of tangible goals was 111.29%, and the progress rate was 7.77%. Conclusion The PDCA cycle has a significant effect on the quality of outpatient prescriptions by increasing the rate of qualification, improving the quality of hospital pharmacy services, and ensuring the safety of patients.

Key words: rehabilitation pharmacy, prescription analysis, plan-do-check-action(PDCA), rational drug use

中图分类号:

R969.3

刘斌, 邵美玲, 蔡怡然, 马丰懿, 兰鸿. 戴明环循环管理在提高门诊处方合理率中的应用价值[J]. 中国药物警戒, 2022, 19(9): 1035-1039.

LIU Bin, SHAO Meiling, CAI Yiran, MA Fengyi, LAN Hong. Applicability of PDCA cycle in standardization of outpatient prescriptions[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1035-1039.

参考文献

[1] Ministry of Health. Prescription Management measures[S]. Decree No. 53 of the Ministry of Health, 2007.
[2] Management Practices of Hospital Prescription Comment(Trial)[S]. National Health and Family Planning Commission State Administration of Traditional Chinese Medicine issued [2010] No. 28. 2010.
[3] Working Group on the revision of guiding principles for Clinical Application of antimicrobials. Guiding principles for clinical application of antibiotics[M]. Beijing: People’s Health Publishing House, 2015.
[4] ZHAO HQ.Understanding and discussion on prescription evaluation in medical institutions[J]. Chinese Journd of Pharmacovigilance(中国药物警戒), 2011, 8(8): 477-479.
[5] Ministry of health. Notice of the General Office of the Ministry of Health on printing and distributing the detailed rules for the implementation of evaluation standards for tertiary general hospitals (2011 Edition): wbygf [2011] No.148[EB/OL]. (2011-12-23)[2021-04-02]. http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=0404f9cd71764ab29b2365e069cfbf2d.
[6] ZHAO XH.Analysis of the application effect of PDCA in the quality management of outpatient and emergency prescriptions[J]. Chinese Prescription Drugs(中国处方药), 2020, 18(10): 45-47.
[7] ZHANG M, WANG CY, Jin YL, et al.Application of PDCA management in key monitoring drug prescription review[J]. Chinese Community Physicians(中国社区医师), 2020, 36(26): 188-189.
[8] GAO SJ.Effect of applying new management method in hospital pharmaceutical management[J]. Continuing Medical Education in China(中国继续医学教育), 2019 ,11(31): 93-95.
[9] ZHAO X, LIN P, GUO J, et al.Pareto diagram analysis of unreasonable drug use in outpatient and emergency departments of our hospital[J]. Chinese Journd of Pharmacovigilance(中国药物警戒), 2018 , 15(7): 429-433.
[10] ZHEN JC, LU J, MEI D, et al.Standard of pharmaceutical care in medical institutions[J]. Medical Bulletin(医药导报), 2019, 38(12): 1535-1556.
[11] YANG MM, FAN P, WEN CH, et al.Analysis and improvement of problems related to the examination of outpatient prescription pharmacists[J]. China Pharmaceutical Industry(中国药业), 2020, 29(8): 64-67.
[12] LIU XX.Analysis of the current situation of drug use among outpatients in a third-class hospital[J]. Journal of Rational Clinical Drug Use(临床合理用药杂志), 2019, 12(10): 1-2.
[13] FAN P, GAO YY, HE LL, et al.Practice and discussion of pharmacist examination and intervention on promoting clinical rational use of statins[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2018,38(19): 2079-2083.
[14] JIANG LW.Study on the causes and countermeasures of unreasonable prescription in western pharmacy[J]. China Medical Guide(中国医药指南), 2020, 18(21): 14-16
[15] ZHAO L, HE XJ, LI XB, et al.Evaluation of drug instructions for cephalosporins commonly used in clinic[J]. Chinese Modern Applied Pharmacy(中国现代应用药学), 2020, 37(15): 1872-1876.
[16] Liu LL.Analysis of unreasonable use of antibiotics in outpatient and emergency respiratory tract infection[J]. Chinese Journd of Pharmacovigilance(中国药物警戒), 2020, 17(8): 513-517
[17] LIU XY, GUO QM, HAN HH, et al.The application effect of quality control circle in improving the reasonable rate of outpatient prescription[J]. Journal of Rational Clinical Drug Use(临床合理用药杂志), 2020, 13(30): 170-172.
[18] HUANG BB.Review and analysis of 1800 outpatient prescriptions in a hospital in 2019[J]. Grass-roots Medical Forum(基层医学论坛), 2020 ,24(25): 3680-3681.
[19] LU YY, LI T, TANG F, et al.Optimization of drug interaction rules in prescription pre-audit system[J]. Chinese Pharmacist(中国药师), 2021, 24(1): 105-108.

戴明环循环管理在提高门诊处方合理率中的应用价值

Applicability of PDCA cycle in standardization of outpatient prescriptions

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	范凯凯, 王聪, 刘洪峰, 王西勇. 临床药师对某院丙氨酰谷氨酰胺注射液应用干预分析[J]. 中国药物警戒, 2024, 21(2): 181-184.
[2]	李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198.
[3]	黎杏仁, 沈爱宗, 苏丹. 质子泵抑制剂预防胆胰外科围术期应激性黏膜病变的合理性评价[J]. 中国药物警戒, 2023, 20(9): 1022-1026.
[4]	史香芬, 孙志勇, 张旭锋, 卢晓静, 杜书章, 张晓坚. 基于智能信息管理系统的门诊麻精药品全流程管理[J]. 中国药物警戒, 2023, 20(8): 899-903.
[5]	霍艳飞, 田月洁, 许莉莉, 谢彦军, 常虹, 孙春晓, 李霞. 535例氢溴酸高乌甲素制剂新的和严重的药品不良反应报告分析[J]. 中国药物警戒, 2023, 20(8): 921-926.
[6]	刘婧, 夏亮, 张世杰. 1例多元药物过敏急性胰腺炎患者行药物激发试验的药学监护[J]. 中国药物警戒, 2023, 20(7): 822-824.
[7]	范秀丛, 董晓慧, 陈丹霞, 鲍思蔚, 马雅斌. 1例妊娠期艰难梭菌感染伴尿路感染患者的药学监护[J]. 中国药物警戒, 2023, 20(5): 579-582.
[8]	殷进军, 王淑伟, 邵姜超, 王冰. 基于加权TOPSIS法的贝伐珠单抗注射液药物利用评价[J]. 中国药物警戒, 2023, 20(12): 1421-1426.
[9]	庄红艳, 臧彦楠, 刘珊珊, 牛梦溪, 房萌, 尹冬青, 果伟. 唑吡坦致神经精神系统不良反应分析[J]. 中国药物警戒, 2022, 19(8): 889-892.
[10]	马冰冰, 张晓朦, 张冰, 林志健, 吕锦涛. 基于文献分析的老年人中成药合理用药与药学服务思考[J]. 中国药物警戒, 2022, 19(6): 595-599.
[11]	李晓菲, 程蓉, 吴雪梅, 刘智. 注射用特利加压素的安全性分析[J]. 中国药物警戒, 2022, 19(6): 654-656.
[12]	陈方方, 张红旭. 大剂量甲氨蝶呤治疗原发性中枢神经系统淋巴瘤的药学实践[J]. 中国药物警戒, 2022, 19(4): 446-449.
[13]	靳浩槟, 郑磊, 杨静, 管玉瑶, 张晓丽. 住院患者皮肤药品不良反应及伴随的肝肾功能异常分析[J]. 中国药物警戒, 2022, 19(3): 310-312.
[14]	徐喆, 鞠萍, 罗琪, 杨欢, 汪洋. 930例儿童抗菌药物不良反应分析[J]. 中国药物警戒, 2022, 19(3): 317-321.
[15]	曹莉莎, 王继生, 张芳, 陈静, 郭濠宁. 631例抗精神病药物药品不良反应分析[J]. 中国药物警戒, 2022, 19(3): 322-324.